Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

1.5K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.5K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

7.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.3K
Introduction to Hemostasis01:05

Introduction to Hemostasis

10.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
10.5K
Coagulation01:09

Coagulation

8.6K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Evolution: Between Hemorrhage and Thrombosis.

Seminars in thrombosis and hemostasis·2026
Same author

Hypophosphatemia in Patients Receiving Intravenous Iron Supplementation for Iron-Deficiency Anemia: A Narrative Review.

Journal of clinical medicine·2026
Same author

Anticoagulant Therapy in Elderly Hospitalized Patients with Atrial Fibrillation: A Critical Appraisal of Data from the Italian REPOSI Registry.

Journal of clinical medicine·2026
Same author

Prescribing cascades among hospitalized older adults: a retrospective cohort study from the REPOSI registry.

Internal and emergency medicine·2026
Same author

Environmental risk factors and cardiovascular health.

European heart journal·2026
Same author

Consideration on 'Exploring the link between dietary inflammatory index, inflammatory biomarkers, and sleep quality in adults with obesity: a pilot investigation'.

International journal of obesity (2005)·2025

Related Experiment Video

Updated: Oct 30, 2025

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.3K

Bleeding Disorders in Primary Fibrinolysis.

Massimo Franchini1, Marco Zaffanello2, Pier Mannuccio Mannucci3

  • 1Department of Transfusion Medicine and Hematology, Carlo Poma Hospital, 46100 Mantova, Italy.

International Journal of Molecular Sciences
|July 2, 2021
PubMed
Summary

Disorders in fibrinolysis, the process of dissolving blood clots, can cause bleeding. This review covers congenital and acquired conditions leading to hyperfibrinolysis and bleeding phenotypes in all age groups.

Keywords:
acquiredbleedinghemorrhageinheritedprimary hyperfibrinolysis

More Related Videos

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.7K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.8K

Related Experiment Videos

Last Updated: Oct 30, 2025

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
06:16

Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models

Published on: April 19, 2024

1.3K
Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
07:09

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States

Published on: April 1, 2015

11.7K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.8K

Area of Science:

  • Biochemistry
  • Hematology
  • Pathophysiology

Background:

  • Fibrinolysis is a critical enzymatic process for dissolving blood clots.
  • The fibrinolytic system regulates fibrin degradation to maintain hemostatic balance.
  • Dysregulation of fibrinolysis can lead to prothrombotic or hemorrhagic conditions.

Purpose of the Study:

  • To review congenital and acquired disorders of primary fibrinolysis.
  • To focus on hyperfibrinolytic states with a bleeding phenotype.
  • To cover these disorders in both adults and children.

Main Methods:

  • Narrative review of existing literature.
  • Synthesis of information on fibrinolysis disorders.
  • Analysis of hyperfibrinolytic states and bleeding phenotypes.

Main Results:

  • Identified various congenital and acquired disorders of primary fibrinolysis.
  • Characterized conditions associated with hyperfibrinolysis.
  • Highlighted the resulting bleeding phenotype in affected individuals.

Conclusions:

  • Disorders of primary fibrinolysis, particularly hyperfibrinolytic states, are significant causes of bleeding.
  • Understanding these conditions is crucial for diagnosis and management in both pediatric and adult populations.
  • Further research into the mechanisms and treatments of fibrinolysis disorders is warranted.